{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "15aa63bd-ca08-414f-af89-837624e6a571",
   "metadata": {},
   "source": [
    "## ColExpand"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "36796b0d-a05b-4d17-8941-e6bce3ececcb",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "d644c9d2-62b1-4391-9929-5dffbc5345d5",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "columns = [\n",
    "    'SRP', 'ACCESSION', 'RUN_SET.RUN.IDENTIFIERS.PRIMARY_ID', \n",
    "    'SAMPLE.SAMPLE_NAME.TAXON_ID', 'Pool.Member.@sample_title', 'TAG', 'VALUE']\n",
    "dF = pd.read_table('SRP_dump/TE_SRP_expanded.csv',delimiter=',') \n",
    "dF = pd.DataFrame(dF, columns=columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "e43edcf2-8c32-476f-a968-365e442fa902",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "tags = list(set(dF['TAG']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "5252aa4b-e0ae-4646-b9b3-7dbbd282f9c9",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "groups = dF.groupby(['ACCESSION']).groups\n",
    "expanded = []\n",
    "for acc in groups:\n",
    "    gr = dF.iloc[[*groups[acc]]]\n",
    "    obj = dict(zip(gr['TAG'], gr['VALUE']))\n",
    "    for col in columns[0:-2]:\n",
    "        obj[col] = list(gr[col])[0]\n",
    "    expanded.append({k:obj[k] for k in obj if obj[k] != \"\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "d3897e41-3b83-4b5a-9532-55c0587e68a2",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "pd.DataFrame(expanded, columns=columns[0:-2] + tags).to_csv(\"SRP_dump/TE_SRP_tagvalue.tsv\", index=False, sep=\"\\t\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "3f72a783-2366-4e39-be20-6177c515f128",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "# replicate (EMPTY: 96.10%)\n",
      "   (19)  Replicate 2\n",
      "   (19)  Replicate 1\n",
      "   (16)  Replicate 3\n",
      "   (10)  Replicate #2\n",
      "   (10)  Replicate #1\n",
      "   (6)  3\n",
      "   (6)  2\n",
      "   (6)  1\n",
      "# infection (EMPTY: 99.83%)\n",
      "   (1)  PRMT5 shRNA\n",
      "   (1)  WDR77 shRNA\n",
      "   (1)  Scrambled control shRNA_2\n",
      "   (1)  Scrambled control shRNA_1\n",
      "# sequencing_library_method (EMPTY: 99.96%)\n",
      "   (1)  Illumina Nextera XT\n",
      "# lab_host (EMPTY: 99.96%)\n",
      "   (1)  Bos taurus\n",
      "# passage_history (EMPTY: 99.96%)\n",
      "   (1)  Passaged once in LFBK-_V_6 cells\n",
      "# serotype (EMPTY: 99.96%)\n",
      "   (1)  A\n",
      "# case history of originator (EMPTY: 99.75%)\n",
      "   (6)  HBs-Ag positive hepato cellular carcinoma (Ed.III) with liver cirrhosis. HBs-Ag(+), HBs-Ab(-), HBe-Ag(-), HBe-Ab(+), HBc-Ab(+), AFP positive (110,000 ng/ml).\n",
      "# genotype/variation (EMPTY: 98.09%)\n",
      "   (12)  expressing sgRNA targeting PRMT5\n",
      "   (7)  PRMT5 knockdown\n",
      "   (6)  No knockdown\n",
      "   (3)  shPRMT5\n",
      "   (3)  shCTRL\n",
      "   (2)  Expressing Dox inducible GFP-SMN fusion protein. Construct is hygromycin resistant.\n",
      "   (2)  Expressing shRNA targeting SMN under CMV promoter.\n",
      "   (2)  Expressing shRNA targeting GFP under CMV promoter.\n",
      "   (1)  Wild type\n",
      "   (1)  Expressing amanitin-resistant R1810A mutant POLR2A\n",
      "   (1)  Expressing amanitin-resistant wt POLR2A\n",
      "   (1)  control\n",
      "   (1)  siNC-2\n",
      "   (1)  siNC-1\n",
      "   (1)  siPRMT5-2\n",
      "   (1)  siPRMT5-1\n",
      "# timepoint_days_post_infection (EMPTY: 99.96%)\n",
      "   (1)  3\n",
      "# stress (EMPTY: 99.49%)\n",
      "   (6)  2 Gy radiation\n",
      "   (6)  0 Gy radiation\n",
      "# polysome fraction (EMPTY: 99.49%)\n",
      "   (3)  bound with three or more ribosomes\n",
      "   (3)  bound with two ribosomes\n",
      "   (3)  bound with one ribosome (monosome)\n",
      "   (3)  total input\n",
      "# biological replicates (EMPTY: 99.32%)\n",
      "   (6)  BR3\n",
      "   (6)  BR2\n",
      "   (4)  BR1\n",
      "# barcode (EMPTY: 97.97%)\n",
      "   (4)  SI-TT-F6\n",
      "   (4)  SI-TT-E5\n",
      "   (4)  SI-TT-D4\n",
      "   (4)  SI-TT-C3\n",
      "   (4)  SI-TT-B2\n",
      "   (4)  SI-TT-A1\n",
      "   (4)  SI-TT-G6\n",
      "   (4)  SI-TT-F5\n",
      "   (4)  SI-TT-E4\n",
      "   (4)  SI-TT-D3\n",
      "   (4)  SI-TT-C2\n",
      "   (4)  SI-TT-B1\n",
      "# isolation_source (EMPTY: 99.96%)\n",
      "   (1)  laboratory / experimental\n",
      "# knockdown (EMPTY: 98.94%)\n",
      "   (6)  shpICln\n",
      "   (6)  shMEP50\n",
      "   (4)  shPRMT5\n",
      "   (3)  MEP50 knockdown\n",
      "   (3)  PRMT5 knockdown\n",
      "   (3)  GFP (control knockdown)\n",
      "# age (EMPTY: 99.75%)\n",
      "   (6)  48Y\n",
      "# note (EMPTY: 99.96%)\n",
      "   (1)  Experimental inocculum was A24/Cruzeiro/BoPass2 Harvested 28Dec2005, SRA accession: SRP149386\n",
      "# donor id (EMPTY: 99.83%)\n",
      "   (2)  CB12\n",
      "   (2)  CB11\n",
      "# cell line background (EMPTY: 99.75%)\n",
      "   (6)  MCF7\n",
      "# reference genome (EMPTY: 99.49%)\n",
      "   (12)  human genome hg38\n",
      "# source_name (EMPTY: 77.18%)\n",
      "   (32)  PBMC\n",
      "   (24)  HEK293T cell line\n",
      "   (22)  Z-138 cells\n",
      "   (20)  cell line VCaP\n",
      "   (20)  Pancreatic cancer cell line\n",
      "   (20)  Osteosarcoma\n",
      "   (18)  Cancer cell line\n",
      "   (16)  Molm13\n",
      "   (16)  Human castration-resistant prostate cancer cells 22Rv1\n",
      "   (16)  Lymph Node\n",
      "   (12)  Prostate cancer\n",
      "   (12)  SUDHL6 cells\n",
      "   (12)  CHL1 cell line\n",
      "   (12)  CHL1AR991 cell line\n",
      "   (12)  A375 cell line\n",
      "   (12)  A375AR991 cell line\n",
      "   (12)  breast cancer cells\n",
      "   (9)  A549\n",
      "   (8)  CD34+ HSPCs from cord blood\n",
      "   (8)  T cells\n",
      "   (8)  Endometrium\n",
      "   (8)  CHL1\n",
      "   (7)  Raji (lymphocyte)\n",
      "   (6)  HEK293\n",
      "   (6)  HCT116 stable cells with E2F1 knockdown\n",
      "   (6)  HCT116 stable cells\n",
      "   (6)  Melanoma, Verafinib\n",
      "   (6)  Melanoma, untreated\n",
      "   (6)  Human lung adenocarcinoma cell line\n",
      "   (5)  U2OS cells\n",
      "   (4)  Hela cells (cervical cancer cells)\n",
      "   (4)  CellLine: SU-DHL-4\n",
      "   (4)  CellLine: SU-DHL-5\n",
      "   (4)  CellLine: SU-DHL-6\n",
      "   (4)  CellLine: JVM-2\n",
      "   (4)  CellLine: MAVER-1\n",
      "   (4)  Acute myeloid leukemia cell line\n",
      "   (4)  HeLa cell\n",
      "   (4)  doxorubicin-resistant MCF7 (MCF7-DR)\n",
      "   (4)  parental MCF7\n",
      "   (3)  AML cell line (MV4-11)_scrambled\n",
      "   (3)  AML cell line (MV4-11)_PMRT5/Knockdown\n",
      "   (3)  A549 lung adenocarcinoma MEP50 shRNA knockdown\n",
      "   (3)  A549 lung adenocarcinoma PRMT5 shRNA knockdown\n",
      "   (3)  A549 lung adenocarcinoma control (GFP) knockdown\n",
      "   (3)  U-87 MG cells, EPZ015666\n",
      "   (3)  U-87 MG cells, DMSO\n",
      "   (3)  MCF7 shPRMT5 ESA+CD24lowCD44+ cells\n",
      "   (3)  MCF7 shCTRL ESA+CD24lowCD44+ cells\n",
      "   (3)  KK U2OS stable cells\n",
      "   (3)  R109K U2OS stable cells\n",
      "   (3)  WT U2OS stable cells\n",
      "   (3)  pTRE U2OS stable cells\n",
      "   (3)  96h PF-9927 activated CD3+\n",
      "   (3)  96h DMSO activated CD3+\n",
      "   (3)  72h PF-9927 activated CD8+\n",
      "   (3)  72h DMSO activated CD8+\n",
      "   (3)  Na√Øve CD8+\n",
      "   (3)  72h PF-9927 activated CD4+\n",
      "   (3)  shPRMT5, JHH-7 cells\n",
      "   (3)  Vector, JHH-7 cells\n",
      "   (3)  HCT116 CCL-247_WT PRMT5\n",
      "   (3)  HCT116 CCL-247_ADA PRMT5\n",
      "   (3)  bladder cancer cell line UM-UC-3\n",
      "   (3)  bladder cancer cell line T24\n",
      "   (2)  MDA-MB-231\n",
      "   (2)  OCI-Ly7 sgPRMT5 6 days\n",
      "   (2)  OCI-Ly7 sgPRMT5 3 days\n",
      "   (2)  OCI-Ly7 sgPRMT5 0 day\n",
      "   (2)  TMD8 sgPRMT5 6 days\n",
      "   (2)  TMD8 sgPRMT5 3 days\n",
      "   (2)  TMD8 sgPRMT5 0 day\n",
      "   (2)  A375-CTX-72hr\n",
      "   (2)  A375-PD991-72hr\n",
      "   (2)  A375-DMSO-72hr\n",
      "   (2)  72h DMSO activated CD4+\n",
      "   (2)  Tu686_siNC\n",
      "   (2)  Tu686_siPRMT5\n",
      "   (2)  Tu212 cells\n",
      "   (1)  HEK293 cell line transfected with Flag-ZNF224, Flag ChIP\n",
      "   (1)  PRMT5 shRNA\n",
      "   (1)  WDR77 shRNA\n",
      "   (1)  Scrambled control shRNA (control for PRMT5 shRNA)\n",
      "   (1)  Scrambled control shRNA (control for WDR77 shRNA)\n",
      "   (1)  PRMT5\n",
      "   (1)  Input\n",
      "   (1)  NGP cells treated with JSK591 replicate 2\n",
      "   (1)  NGP cells treated with JSK591 replicate 1\n",
      "   (1)  NGP cells treated with DMSO replicate 2\n",
      "   (1)  NGP cells treated with DMSO replicate 1\n",
      "   (1)  CHLA-20 cells treated with JSK591 replicate 2\n",
      "   (1)  CHLA-20 cells treated with JSK591 replicate 1\n",
      "   (1)  CHLA-20 cells treated with DMSO replicate 2\n",
      "   (1)  CHLA-20 cells treated with DMSO replicate 1\n",
      "   (1)  SA-SPLICE19-4_S4\n",
      "   (1)  SA-SPLICE19-3_S3\n",
      "   (1)  SA-SPLICE19-2_S2\n",
      "   (1)  SA-SPLICE19-1_S1\n",
      "# disease (EMPTY: 97.97%)\n",
      "   (32)  Richter's Transformation\n",
      "   (16)  Chronic Lymphocytic Leukemia\n",
      "# treatment (EMPTY: 86.71%)\n",
      "   (24)  No treatment\n",
      "   (21)  DMSO\n",
      "   (16)  DHT\n",
      "   (12)  increasing concentrations of palbociclib for 3 months\n",
      "   (12)  increasing concentrations of palbociclib for 7 months\n",
      "   (10)  untreated\n",
      "   (9)  PRMT5i\n",
      "   (6)  Dox+\n",
      "   (6)  Dox-\n",
      "   (6)  200nm GSK591\n",
      "   (6)  Vehicle (0.01% DMSO)\n",
      "   (6)  Treated (GSK3368712)\n",
      "   (6)  Control (DMSO)\n",
      "   (6)  72h PF-9927\n",
      "   (6)  2 ¬µM Verafinib for 20 days\n",
      "   (6)  Treated with 5¬µM GSK591 and 5¬µM Ro for 24hr\n",
      "   (6)  Treated with 5¬µM Ro for 24hr\n",
      "   (6)  CDK4/6 inhibition\n",
      "   (5)  72h DMSO\n",
      "   (5)  Treated with 5¬µM GSK591 for 24hr\n",
      "   (5)  Treated with DMSO for 24hr\n",
      "   (4)  Infected cells were selected with puromycin (1mg/mL) for 5 days\n",
      "   (4)  R1881\n",
      "   (4)  Treated (Combination)\n",
      "   (4)  Treated (GSK3203591)\n",
      "   (4)  treated with PRMT4 inhibitor\n",
      "   (4)  treated with PRMT1 inhibitor\n",
      "   (4)  treated with DMSO\n",
      "   (4)  parental cells treated with DOX\n",
      "   (4)  parental cells\n",
      "   (4)  treated with 1‚ÄâŒºM doxorubicin hydrochloride\n",
      "   (4)  JSK591\n",
      "   (4)  Control\n",
      "   (3)  EPZ015666\n",
      "   (3)  96h PF-9927\n",
      "   (3)  96h DMSO\n",
      "   (3)  MS023\n",
      "   (3)  GSK591\n",
      "   (3)  PRMT5 shRNA transfection\n",
      "   (3)  Empty vector transfection\n",
      "   (3)  WT\n",
      "   (3)  ADA treatment\n",
      "   (3)  lentivirus infection NCI-H460 for shRNA against PRMT5\n",
      "   (3)  lentivirus infection NCI-H460 for shRNA against GFP\n",
      "   (2)  no treatment\n",
      "   (2)  GSK3326595 (CTX) - 72hr\n",
      "   (2)  Palbociclib (PD991) - 72hr\n",
      "   (2)  Vehicle (DMSO) - 72 hr\n",
      "   (2)  15 ¬µM PF-366\n",
      "   (2)  PRMT7 knockdown\n",
      "   (2)  PRMT5 knockdown\n",
      "   (2)  PRMT4 knockdown\n",
      "   (2)  PRMT3 knockdown\n",
      "   (2)  PRMT1 knockdown\n",
      "   (2)  parental cells overexpressed with PRMT6 under DOX treatment\n",
      "   (2)  parental cells overexpressed with PRMT5 under DOX treatment\n",
      "   (2)  0.04 OD Si-RNA-2\n",
      "   (2)  0.04 OD Si-RNA-1\n",
      "   (2)  Negative control\n",
      "   (2)  PRMT5 inhibition\n",
      "   (1)  5¬µM HPTB for 4 hours at 37¬∞C\n",
      "   (1)  5¬µM DMSO for 4 hours at 37¬∞C\n",
      "   (1)  RPHD19 T cells CD3/CD28 +PRMT5 INHIBITOR\n",
      "   (1)  RPHD19 T cells CD3/CD28 +DMSO\n",
      "   (1)  RPHD18 T cells CD3/CD28 +PRMT5 INHIBITOR\n",
      "   (1)  RPHD18 T cells CD3/CD28 +DMSO\n",
      "   (1)  RPHD17 T cells CD3/CD28 +PRMT5 INHIBITOR\n",
      "   (1)  RPHD17 T cells CD3/CD28 +DMSO\n",
      "   (1)  RPHD7 T cells CD3/CD28 +PRMT5 INHIBITOR\n",
      "   (1)  RPHD7 T cells CD3/CD28 +DMSO\n",
      "   (1)  siPRMT7-HEK293\n",
      "   (1)  siPRMT5-HEK293\n",
      "   (1)  siPRMT4-HEK293\n",
      "   (1)  siCTL-HEK293\n",
      "   (1)  PRMT6 knockdown\n",
      "   (1)  Scramble shRNA control\n",
      "# tissue (EMPTY: 95.77%)\n",
      "   (32)  PBMC\n",
      "   (24)  peripheral blood\n",
      "   (16)  Lymph Node\n",
      "   (12)  breast cancer cells\n",
      "   (8)  Endometrium\n",
      "   (4)  Human Embryonic Kidney\n",
      "   (1)  SA-SPLICE19-4_S4\n",
      "   (1)  SA-SPLICE19-3_S3\n",
      "   (1)  SA-SPLICE19-2_S2\n",
      "   (1)  SA-SPLICE19-1_S1\n",
      "# genotype (EMPTY: 97.21%)\n",
      "   (12)  BRAFV600E\n",
      "   (12)  WT\n",
      "   (8)  control\n",
      "   (7)  PRMT5 knockdown\n",
      "   (6)  MTAP-/-\n",
      "   (5)  XRN2 KD\n",
      "   (5)  PRMT5 KD\n",
      "   (4)  DDX5 KD\n",
      "   (3)  Control\n",
      "   (1)  XRN2 KD input\n",
      "   (1)  PRMT5 KD input\n",
      "   (1)  DDX5 KD input\n",
      "   (1)  PRMT5 overexpression\n",
      "# genetics (EMPTY: 99.83%)\n",
      "   (4)  t(4;11)(q21;q23)\n",
      "# overexpression (EMPTY: 99.07%)\n",
      "   (12)  Overexpressing empty vector\n",
      "   (10)  Overexpressing MSI2-HyperADAR fusion\n",
      "# tumor type (EMPTY: 99.15%)\n",
      "   (12)  Diffuse Large B-cell Lymphoma\n",
      "   (8)  Mantle Cell Lymphoma\n",
      "# isolate (EMPTY: 99.96%)\n",
      "   (1)  non-vaccinated bovine 14-34\n",
      "# geo_loc_name (EMPTY: 99.96%)\n",
      "   (1)  not applicable\n",
      "# chip antibody (EMPTY: 98.52%)\n",
      "   (12)  AR\n",
      "   (8)  ERG\n",
      "   (5)  Monoclonal S9.6\n",
      "   (4)  none\n",
      "   (1)  anti-Flag M2\n",
      "   (1)  PRMT5 (Bethyl Labs A300-849A)\n",
      "   (1)  none (input)\n",
      "   (1)  PRMT5\n",
      "   (1)  MTA1\n",
      "   (1)  Snail\n",
      "# time (EMPTY: 99.32%)\n",
      "   (8)  24h\n",
      "   (4)  48h\n",
      "   (4)  0h\n",
      "# ectopic e2f-1 expressed (EMPTY: 99.49%)\n",
      "   (3)  HA-tagged R111/113K mutated E2F-1 (KK)\n",
      "   (3)  HA-tagged R109K mutated E2F-1\n",
      "   (3)  HA-tagged wild-type E2F-1\n",
      "   (3)  empty vector cell line\n",
      "# treatment2 (EMPTY: 99.66%)\n",
      "   (8)  8-Br-cAMP,MPA\n",
      "# genetic aberration (EMPTY: 99.83%)\n",
      "   (2)  control\n",
      "   (2)  t(4;11)(q21;q23)\n",
      "# shRNA (EMPTY: 99.15%)\n",
      "   (6)  PRMT5 sh2\n",
      "   (5)  PRMT5 sh1\n",
      "   (5)  PRMT5 NTC\n",
      "   (4)  PRMT5 sh3\n",
      "# treated with (EMPTY: 98.65%)\n",
      "   (10)  200nM GSK3326595\n",
      "   (10)  Vehicle\n",
      "   (4)  20ng/ml doxycycline for 6 days.\n",
      "   (4)  20ng/ml doxycycline for 3 days.\n",
      "   (4)  20ng/ml doxycycline for 0 days.\n",
      "# concentration (EMPTY: 99.75%)\n",
      "   (3)  10 uM\n",
      "   (3)  10 ul per 10 ml media\n",
      "# sample_type (EMPTY: 99.96%)\n",
      "   (1)  Saliva\n",
      "# agent (EMPTY: 99.32%)\n",
      "   (8)  Dox +\n",
      "   (8)  Dox -\n",
      "# time point (EMPTY: 97.88%)\n",
      "   (12)  48hr after retrovirus transduction\n",
      "   (10)  Day 6\n",
      "   (10)  Day 3\n",
      "   (10)  48hr after transduction\n",
      "   (6)  72 hours\n",
      "   (2)  6 days\n",
      "# cell line (EMPTY: 82.39%)\n",
      "   (37)  U2OS\n",
      "   (24)  HEK293T\n",
      "   (22)  A375\n",
      "   (22)  Z-138 cells\n",
      "   (20)  VCaP\n",
      "   (20)  CHL1\n",
      "   (18)  HCT116\n",
      "   (16)  PANC03.27\n",
      "   (16)  Molm13\n",
      "   (12)  LNCaP-shPRMT5\n",
      "   (12)  SUDHL6\n",
      "   (12)  CHL1AR991\n",
      "   (12)  A375AR991\n",
      "   (12)  MDA-MB-231\n",
      "   (9)  A549 lung adenocarcinoma\n",
      "   (9)  A549\n",
      "   (8)  breast cancer cell line MDA-MB-231\n",
      "   (6)  MV4-11\n",
      "   (6)  U-87 MG\n",
      "   (6)  OCI-Ly7\n",
      "   (6)  TMD8\n",
      "   (6)  M14s\n",
      "   (6)  A375s\n",
      "   (6)  HCC cell line JHH-7\n",
      "   (6)  H441\n",
      "   (6)  A427\n",
      "   (6)  H1975\n",
      "   (6)  NCI-H460\n",
      "   (5)  HEK293\n",
      "   (4)  Hela\n",
      "   (4)  SU-DHL-4\n",
      "   (4)  SU-DHL-5\n",
      "   (4)  SU-DHL-6\n",
      "   (4)  JVM-2\n",
      "   (4)  MAVER-1\n",
      "   (4)  PANC08.13\n",
      "   (4)  THP-1\n",
      "   (4)  HeLa\n",
      "   (4)  Tu686\n",
      "   (4)  MCF7-DR\n",
      "   (4)  MCF7\n",
      "   (4)  NGP\n",
      "   (4)  CHLA-20\n",
      "   (3)  bladder cancer cell line UM-UC-3\n",
      "   (3)  bladder cancer cell line T24\n",
      "   (2)  Tu212\n",
      "# tissue source (EMPTY: 97.46%)\n",
      "   (54)  Melanoma\n",
      "   (6)  Colorectal\n",
      "# treatment1 (EMPTY: 99.66%)\n",
      "   (4)  GSK591\n",
      "   (4)  solvent\n",
      "# BioSampleModel (EMPTY: 99.96%)\n",
      "   (1)  Viral\n",
      "# antibody (EMPTY: 99.53%)\n",
      "   (2)  RNAPII (N20) (Santa Cruz pAb Cat # sc-899)\n",
      "   (2)  RNAPII CTD, phospho-S5 (4h8) (Abcam mAb Cat # ab5408)\n",
      "   (2)  RNAPII CTD (8wg16) (purified in the lab)\n",
      "   (2)  SRSF1 antibody\n",
      "   (1)  IgG (Invitrogen Cat # 10500C)\n",
      "   (1)  GFP (Abcam pAb Cat# 290)\n",
      "   (1)  SMN (Santa Cruz pAb Cat # H-195)\n",
      "# collection_date (EMPTY: 99.96%)\n",
      "   (1)  not applicable\n",
      "# mtap status (EMPTY: 99.15%)\n",
      "   (8)  Knock out\n",
      "   (8)  Parental\n",
      "   (4)  nan\n",
      "# incubation time (EMPTY: 99.75%)\n",
      "   (6)  72h\n",
      "# vector (EMPTY: 99.49%)\n",
      "   (3)  E2F1 knockdown cell line treated with PRMT5 inhibitor\n",
      "   (3)  E2F1 knockdown cell line\n",
      "   (3)  empty vector cell line treated with PRMT5 inhibitor\n",
      "   (3)  empty vector cell line\n",
      "# conditions (EMPTY: 99.03%)\n",
      "   (12)  1ug/ml doxycycline, 24h\n",
      "   (6)  PRMT5 inhibitor treatment: 1uM, 48h\n",
      "   (2)  25nM p100/TSN siRNA, 72h\n",
      "   (2)  25nM NT siRNA, 72h\n",
      "   (1)  25nM E2F-1 siRNA, 72h\n",
      "# transfection (EMPTY: 99.79%)\n",
      "   (2)  esiRNA targeting PRMT9 (1ug esiRNA/10cm dish)\n",
      "   (2)  control esiRNA\n",
      "   (1)  Flag-ZNF224\n",
      "# condition (EMPTY: 99.32%)\n",
      "   (4)  PRMT5 and EZH2 Inhibition\n",
      "   (4)  PRMT5 Inhibition\n",
      "   (4)  EZH2 Inhibition\n",
      "   (4)  DMSO Control\n",
      "# cell type (EMPTY: 93.35%)\n",
      "   (22)  Mantle cell lymphoma cell line\n",
      "   (20)  Naive T lymphocytes\n",
      "   (17)  Osteosarcoma, epithelial\n",
      "   (16)  Acute Myeloid Leukemia\n",
      "   (12)  Colorectal carcinoma\n",
      "   (12)  melanoma cell\n",
      "   (9)  epithelial\n",
      "   (8)  stromal cells\n",
      "   (7)  Raji (EBNA 1 positive)\n",
      "   (6)  ESA+CD24lowCD44+ cells\n",
      "   (6)  GCB DLBCL cell line\n",
      "   (6)  ABC DLBCL cell line\n",
      "   (6)  Epithelial-derived cells\n",
      "   (4)  CD34+ HSPCs from cord blood\n",
      "   (4)  monocyte\n",
      "   (2)  HEK293\n",
      "# culture type (EMPTY: 99.83%)\n",
      "   (4)  suspension\n",
      "# time of treatment (EMPTY: 99.49%)\n",
      "   (6)  96 h\n",
      "   (6)  24 h\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[('source_name', 77.18035563082134),\n",
       " ('cell line', 82.38780694326842),\n",
       " ('treatment', 86.70618120237087),\n",
       " ('cell type', 93.35309060118544),\n",
       " ('tissue', 95.76629974597799),\n",
       " ('replicate', 96.10499576629975),\n",
       " ('genotype', 97.20575783234547),\n",
       " ('tissue source', 97.45977984758679),\n",
       " ('time point', 97.883149872989),\n",
       " ('barcode', 97.96782387806944),\n",
       " ('disease', 97.96782387806944),\n",
       " ('genotype/variation', 98.09483488569009),\n",
       " ('chip antibody', 98.5182049110923),\n",
       " ('treated with', 98.64521591871296),\n",
       " ('knockdown', 98.94157493649449),\n",
       " ('conditions', 99.02624894157493),\n",
       " ('overexpression', 99.06858594411516),\n",
       " ('tumor type', 99.15325994919559),\n",
       " ('shRNA', 99.15325994919559),\n",
       " ('mtap status', 99.15325994919559),\n",
       " ('biological replicates', 99.32260795935647),\n",
       " ('time', 99.32260795935647),\n",
       " ('agent', 99.32260795935647),\n",
       " ('condition', 99.32260795935647),\n",
       " ('stress', 99.49195596951735),\n",
       " ('polysome fraction', 99.49195596951735),\n",
       " ('reference genome', 99.49195596951735),\n",
       " ('ectopic e2f-1 expressed', 99.49195596951735),\n",
       " ('vector', 99.49195596951735),\n",
       " ('time of treatment', 99.49195596951735),\n",
       " ('antibody', 99.53429297205759),\n",
       " ('treatment2', 99.66130397967824),\n",
       " ('treatment1', 99.66130397967824),\n",
       " ('case history of originator', 99.74597798475868),\n",
       " ('age', 99.74597798475868),\n",
       " ('cell line background', 99.74597798475868),\n",
       " ('concentration', 99.74597798475868),\n",
       " ('incubation time', 99.74597798475868),\n",
       " ('transfection', 99.7883149872989),\n",
       " ('infection', 99.83065198983911),\n",
       " ('donor id', 99.83065198983911),\n",
       " ('genetics', 99.83065198983911),\n",
       " ('genetic aberration', 99.83065198983911),\n",
       " ('culture type', 99.83065198983911),\n",
       " ('sequencing_library_method', 99.95766299745978),\n",
       " ('lab_host', 99.95766299745978),\n",
       " ('passage_history', 99.95766299745978),\n",
       " ('serotype', 99.95766299745978),\n",
       " ('timepoint_days_post_infection', 99.95766299745978),\n",
       " ('isolation_source', 99.95766299745978),\n",
       " ('note', 99.95766299745978),\n",
       " ('isolate', 99.95766299745978),\n",
       " ('geo_loc_name', 99.95766299745978),\n",
       " ('sample_type', 99.95766299745978),\n",
       " ('BioSampleModel', 99.95766299745978),\n",
       " ('collection_date', 99.95766299745978)]"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def counts(obj):\n",
    "    cntx = {}\n",
    "    for c in list(obj):\n",
    "        if c not in cntx: cntx[c] = 0\n",
    "        cntx[c] += 1\n",
    "    return sorted(cntx.items(), key=lambda item: item[1], reverse=True)\n",
    "\n",
    "filtred = []\n",
    "stats = {}\n",
    "total = max(dF.count())\n",
    "for tag in tags:\n",
    "    cntx = counts(dF[dF.TAG == tag]['VALUE'])\n",
    "    empty = 100 * ( 1 - sum([v for k,v in cntx])/total )\n",
    "    stats[tag] = empty\n",
    "    if empty < 99.5:\n",
    "        filtred.append(tag)\n",
    "    print(f\"# {tag} (EMPTY: {empty:.2f}%)\")\n",
    "    for k, v in cntx:\n",
    "        print(f\"   ({v})  {k}\")\n",
    "\n",
    "[(k,v) for k,v in sorted(stats.items(), key=lambda item: item[1])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "f84847ab-c00c-41d5-b1b3-dda1d68c28c4",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "pd.DataFrame(expanded, columns=columns[0:-2] + filtred).to_csv(\"SRP_dump/TE_SRP_tagvalue_filterd.tsv\", index=False, sep=\"\\t\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1706c744-93d1-493a-98c4-b2c6328a1c1c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
